Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
820
Trial Sponsor
Clinical Trial Start Date
2016
0Primary Completion Date
2016
0Study Completion Date
2016
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Drug0
Intervention Name
Palonosetron0
Moxifloxacin0
Placebo0
Exenatide0
Interventional Trial Phase
Phase 10
Official Name
Two-Part, Randomized, Placebo and Active-Controlled, Double-Blind, Thorough QT Study Evaluating the Effects of Intravenous Exenatide on Cardiac Repolarization in Healthy Male and Female Volunteers0
Last Updated
January 27, 2017
0Allocation Type
Randomized0
Intervention Model
Crossover Assignment0
Masking Type
Quadruple0
Masked Party
Care Provider0
Outcomes Assessor0
Participant0
Investigator0
Study summary
Two-Part, Randomized, Placebo and Active-Controlled, Double-Blind, Thorough QT Study Evaluating the Effects of Intravenous Exenatide on Cardiac Repolarization in Healthy Male and Female Volunteers
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
